- Home
- AYTU vs MITQ Comparison
AYTU vs MITQ Comparison
Compare AYTU & MITQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AYTU
- MITQ
- Stock Information
- Founded
- AYTU N/A
- MITQ N/A
- Country
- AYTU United States
- MITQ United States
- Employees
- AYTU N/A
- MITQ N/A
- Industry
- AYTU Biotechnology: Pharmaceutical Preparations
- MITQ Telecommunications Equipment
- Sector
- AYTU Health Care
- MITQ Telecommunications
- Exchange
- AYTU Nasdaq
- MITQ Nasdaq
- Market Cap
- AYTU 8.3M
- MITQ 7.3M
- IPO Year
- AYTU N/A
- MITQ 2021
- Fundamental
- Price
- AYTU $1.10
- MITQ $0.60
- Analyst Decision
- AYTU
- MITQ
- Analyst Count
- AYTU 0
- MITQ 0
- Target Price
- AYTU N/A
- MITQ N/A
- AVG Volume (30 Days)
- AYTU 30.8K
- MITQ 343.5K
- Earning Date
- AYTU 05-14-2025
- MITQ 05-14-2025
- Dividend Yield
- AYTU N/A
- MITQ N/A
- EPS Growth
- AYTU N/A
- MITQ N/A
- EPS
- AYTU N/A
- MITQ N/A
- Revenue
- AYTU $77,232,000.00
- MITQ $18,932,000.00
- Revenue This Year
- AYTU N/A
- MITQ N/A
- Revenue Next Year
- AYTU $8.14
- MITQ N/A
- P/E Ratio
- AYTU N/A
- MITQ N/A
- Revenue Growth
- AYTU N/A
- MITQ N/A
- 52 Week Low
- AYTU $0.95
- MITQ $0.42
- 52 Week High
- AYTU $3.45
- MITQ $1.55
- Technical
- Relative Strength Index (RSI)
- AYTU 42.38
- MITQ 44.67
- Support Level
- AYTU $0.99
- MITQ $0.52
- Resistance Level
- AYTU $1.10
- MITQ $0.69
- Average True Range (ATR)
- AYTU 0.08
- MITQ 0.08
- MACD
- AYTU 0.01
- MITQ -0.01
- Stochastic Oscillator
- AYTU 50.00
- MITQ 12.51
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.
About MITQ Moving iMage Technologies Inc.
Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.